Aurora B: a new prognostic marker and therapeutic target in cancer
- PMID: 21143115
- DOI: 10.2174/092986711794480203
Aurora B: a new prognostic marker and therapeutic target in cancer
Abstract
Aurora B is a serine-threonine kinase belonging to the highly conserved Aurora family of mitotic kinases. Aurora B is a chromosomal passenger protein involved in chromosome segregation, spindle-checkpoint, and cytokinesis. Alteration of each of these steps could induce aneuploidy, one of main features, and driving force of cancer progression. The overexpression of Aurora B has been observed in several tumor types, and has been linked with a poor prognosis of cancer patients. In this review we will focus on the role of Aurora B in cancer development, its role as a prognostic marker, and the clinical outcome of recently developed Aurora(s) inhibitors.
© 2011 Bentham Science Publishers Ltd.
Similar articles
-
Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.Pharmacol Ther. 2006 Sep;111(3):974-84. doi: 10.1016/j.pharmthera.2006.02.006. Epub 2006 Apr 17. Pharmacol Ther. 2006. PMID: 16603252 Review.
-
Aurora-B kinase inhibitors for cancer chemotherapy.Mini Rev Med Chem. 2008 Dec;8(14):1514-25. doi: 10.2174/138955708786786480. Mini Rev Med Chem. 2008. PMID: 19075809 Review.
-
Targeting aurora kinases in cancer treatment.Curr Drug Targets. 2011 Dec;12(14):2067-78. doi: 10.2174/138945011798829410. Curr Drug Targets. 2011. PMID: 21777198 Review.
-
Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.Curr Cancer Drug Targets. 2012 Jul;12(6):625-39. doi: 10.2174/156800912801784839. Curr Cancer Drug Targets. 2012. PMID: 22463590
-
Clinical experience with aurora kinase inhibitors: a review.Oncologist. 2009 Aug;14(8):780-93. doi: 10.1634/theoncologist.2009-0019. Epub 2009 Aug 14. Oncologist. 2009. PMID: 19684075 Review.
Cited by
-
AURKB/CDC37 complex promotes clear cell renal cell carcinoma progression via phosphorylating MYC and constituting an AURKB/E2F1-positive feedforward loop.Cell Death Dis. 2024 Jun 18;15(6):427. doi: 10.1038/s41419-024-06827-y. Cell Death Dis. 2024. PMID: 38890303 Free PMC article.
-
The structural basis of the multi-step allosteric activation of Aurora B kinase.Elife. 2023 May 25;12:e85328. doi: 10.7554/eLife.85328. Elife. 2023. PMID: 37227118 Free PMC article.
-
Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.Mol Cancer. 2016 Feb 3;15:12. doi: 10.1186/s12943-016-0494-6. Mol Cancer. 2016. PMID: 26842935 Free PMC article.
-
miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update.Int J Mol Sci. 2021 Jan 30;22(3):1380. doi: 10.3390/ijms22031380. Int J Mol Sci. 2021. PMID: 33573132 Free PMC article. Review.
-
The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.Drug Des Devel Ther. 2015 Feb 17;9:1027-62. doi: 10.2147/DDDT.S74412. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25733818 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
